Oral Vaccines Market Report

Global Oral Vaccines Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Feb 28, 2022
  • PAGES：143
  • REPORT CODE：GMM781254
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Oral Vaccines market report explains the definition, types, applications, major countries, and major players of the Oral Vaccines market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Halfkin Bio-Pharmaceuticals

    • GSK

    • Serum Institute

    • Valneva

    • Merck

    • Shanghai United Cell

    • Sanofi

    • Bibcol

    • Bio-Med

    • Tiantan Biological

    • PaxVax

    • EuBiologics

    • Panacea Biotec Ltd

    • Vabiotech

    • Lanzhou Institute

    By Type:

    • Rotavirus Vaccine

    • Cholera Vaccine

    • Oral Polio Vaccine

    • Others

    By End-User:

    • Public

    • Private

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Oral Vaccines Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Oral Vaccines Outlook to 2028- Original Forecasts

    • 2.2 Oral Vaccines Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Oral Vaccines Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Oral Vaccines Market- Recent Developments

    • 6.1 Oral Vaccines Market News and Developments

    • 6.2 Oral Vaccines Market Deals Landscape

    7 Oral Vaccines Raw Materials and Cost Structure Analysis

    • 7.1 Oral Vaccines Key Raw Materials

    • 7.2 Oral Vaccines Price Trend of Key Raw Materials

    • 7.3 Oral Vaccines Key Suppliers of Raw Materials

    • 7.4 Oral Vaccines Market Concentration Rate of Raw Materials

    • 7.5 Oral Vaccines Cost Structure Analysis

      • 7.5.1 Oral Vaccines Raw Materials Analysis

      • 7.5.2 Oral Vaccines Labor Cost Analysis

      • 7.5.3 Oral Vaccines Manufacturing Expenses Analysis

    8 Global Oral Vaccines Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Oral Vaccines Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Oral Vaccines Export by Region (Top 10 Countries) (2017-2028)

    9 Global Oral Vaccines Market Outlook by Types and Applications to 2022

    • 9.1 Global Oral Vaccines Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Rotavirus Vaccine Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Cholera Vaccine Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Oral Polio Vaccine Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Oral Vaccines Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Public Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Private Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Oral Vaccines Market Analysis and Outlook till 2022

    • 10.1 Global Oral Vaccines Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Oral Vaccines Consumption (2017-2022)

      • 10.2.2 Canada Oral Vaccines Consumption (2017-2022)

      • 10.2.3 Mexico Oral Vaccines Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Oral Vaccines Consumption (2017-2022)

      • 10.3.2 UK Oral Vaccines Consumption (2017-2022)

      • 10.3.3 Spain Oral Vaccines Consumption (2017-2022)

      • 10.3.4 Belgium Oral Vaccines Consumption (2017-2022)

      • 10.3.5 France Oral Vaccines Consumption (2017-2022)

      • 10.3.6 Italy Oral Vaccines Consumption (2017-2022)

      • 10.3.7 Denmark Oral Vaccines Consumption (2017-2022)

      • 10.3.8 Finland Oral Vaccines Consumption (2017-2022)

      • 10.3.9 Norway Oral Vaccines Consumption (2017-2022)

      • 10.3.10 Sweden Oral Vaccines Consumption (2017-2022)

      • 10.3.11 Poland Oral Vaccines Consumption (2017-2022)

      • 10.3.12 Russia Oral Vaccines Consumption (2017-2022)

      • 10.3.13 Turkey Oral Vaccines Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Oral Vaccines Consumption (2017-2022)

      • 10.4.2 Japan Oral Vaccines Consumption (2017-2022)

      • 10.4.3 India Oral Vaccines Consumption (2017-2022)

      • 10.4.4 South Korea Oral Vaccines Consumption (2017-2022)

      • 10.4.5 Pakistan Oral Vaccines Consumption (2017-2022)

      • 10.4.6 Bangladesh Oral Vaccines Consumption (2017-2022)

      • 10.4.7 Indonesia Oral Vaccines Consumption (2017-2022)

      • 10.4.8 Thailand Oral Vaccines Consumption (2017-2022)

      • 10.4.9 Singapore Oral Vaccines Consumption (2017-2022)

      • 10.4.10 Malaysia Oral Vaccines Consumption (2017-2022)

      • 10.4.11 Philippines Oral Vaccines Consumption (2017-2022)

      • 10.4.12 Vietnam Oral Vaccines Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Oral Vaccines Consumption (2017-2022)

      • 10.5.2 Colombia Oral Vaccines Consumption (2017-2022)

      • 10.5.3 Chile Oral Vaccines Consumption (2017-2022)

      • 10.5.4 Argentina Oral Vaccines Consumption (2017-2022)

      • 10.5.5 Venezuela Oral Vaccines Consumption (2017-2022)

      • 10.5.6 Peru Oral Vaccines Consumption (2017-2022)

      • 10.5.7 Puerto Rico Oral Vaccines Consumption (2017-2022)

      • 10.5.8 Ecuador Oral Vaccines Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Oral Vaccines Consumption (2017-2022)

      • 10.6.2 Kuwait Oral Vaccines Consumption (2017-2022)

      • 10.6.3 Oman Oral Vaccines Consumption (2017-2022)

      • 10.6.4 Qatar Oral Vaccines Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Oral Vaccines Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Oral Vaccines Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Oral Vaccines Consumption (2017-2022)

      • 10.7.2 South Africa Oral Vaccines Consumption (2017-2022)

      • 10.7.3 Egypt Oral Vaccines Consumption (2017-2022)

      • 10.7.4 Algeria Oral Vaccines Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Oral Vaccines Consumption (2017-2022)

      • 10.8.2 New Zealand Oral Vaccines Consumption (2017-2022)

    11 Global Oral Vaccines Competitive Analysis

    • 11.1 Halfkin Bio-Pharmaceuticals

      • 11.1.1 Halfkin Bio-Pharmaceuticals Company Details

      • 11.1.2 Halfkin Bio-Pharmaceuticals Oral Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Halfkin Bio-Pharmaceuticals Oral Vaccines Main Business and Markets Served

      • 11.1.4 Halfkin Bio-Pharmaceuticals Oral Vaccines Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 GSK

      • 11.2.1 GSK Company Details

      • 11.2.2 GSK Oral Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 GSK Oral Vaccines Main Business and Markets Served

      • 11.2.4 GSK Oral Vaccines Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Serum Institute

      • 11.3.1 Serum Institute Company Details

      • 11.3.2 Serum Institute Oral Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Serum Institute Oral Vaccines Main Business and Markets Served

      • 11.3.4 Serum Institute Oral Vaccines Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Valneva

      • 11.4.1 Valneva Company Details

      • 11.4.2 Valneva Oral Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Valneva Oral Vaccines Main Business and Markets Served

      • 11.4.4 Valneva Oral Vaccines Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Merck

      • 11.5.1 Merck Company Details

      • 11.5.2 Merck Oral Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Merck Oral Vaccines Main Business and Markets Served

      • 11.5.4 Merck Oral Vaccines Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Shanghai United Cell

      • 11.6.1 Shanghai United Cell Company Details

      • 11.6.2 Shanghai United Cell Oral Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Shanghai United Cell Oral Vaccines Main Business and Markets Served

      • 11.6.4 Shanghai United Cell Oral Vaccines Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Sanofi

      • 11.7.1 Sanofi Company Details

      • 11.7.2 Sanofi Oral Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Sanofi Oral Vaccines Main Business and Markets Served

      • 11.7.4 Sanofi Oral Vaccines Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Bibcol

      • 11.8.1 Bibcol Company Details

      • 11.8.2 Bibcol Oral Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Bibcol Oral Vaccines Main Business and Markets Served

      • 11.8.4 Bibcol Oral Vaccines Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Bio-Med

      • 11.9.1 Bio-Med Company Details

      • 11.9.2 Bio-Med Oral Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Bio-Med Oral Vaccines Main Business and Markets Served

      • 11.9.4 Bio-Med Oral Vaccines Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Tiantan Biological

      • 11.10.1 Tiantan Biological Company Details

      • 11.10.2 Tiantan Biological Oral Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Tiantan Biological Oral Vaccines Main Business and Markets Served

      • 11.10.4 Tiantan Biological Oral Vaccines Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    • 11.11 PaxVax

      • 11.11.1 PaxVax Company Details

      • 11.11.2 PaxVax Oral Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.11.3 PaxVax Oral Vaccines Main Business and Markets Served

      • 11.11.4 PaxVax Oral Vaccines Product Portfolio

      • 11.11.5 Recent Research and Development Strategies

    • 11.12 EuBiologics

      • 11.12.1 EuBiologics Company Details

      • 11.12.2 EuBiologics Oral Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.12.3 EuBiologics Oral Vaccines Main Business and Markets Served

      • 11.12.4 EuBiologics Oral Vaccines Product Portfolio

      • 11.12.5 Recent Research and Development Strategies

    • 11.13 Panacea Biotec Ltd

      • 11.13.1 Panacea Biotec Ltd Company Details

      • 11.13.2 Panacea Biotec Ltd Oral Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.13.3 Panacea Biotec Ltd Oral Vaccines Main Business and Markets Served

      • 11.13.4 Panacea Biotec Ltd Oral Vaccines Product Portfolio

      • 11.13.5 Recent Research and Development Strategies

    • 11.14 Vabiotech

      • 11.14.1 Vabiotech Company Details

      • 11.14.2 Vabiotech Oral Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.14.3 Vabiotech Oral Vaccines Main Business and Markets Served

      • 11.14.4 Vabiotech Oral Vaccines Product Portfolio

      • 11.14.5 Recent Research and Development Strategies

    • 11.15 Lanzhou Institute

      • 11.15.1 Lanzhou Institute Company Details

      • 11.15.2 Lanzhou Institute Oral Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.15.3 Lanzhou Institute Oral Vaccines Main Business and Markets Served

      • 11.15.4 Lanzhou Institute Oral Vaccines Product Portfolio

      • 11.15.5 Recent Research and Development Strategies

    12 Global Oral Vaccines Market Outlook by Types and Applications to 2028

    • 12.1 Global Oral Vaccines Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Rotavirus Vaccine Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Cholera Vaccine Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Oral Polio Vaccine Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Oral Vaccines Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Public Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Private Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Oral Vaccines Market Analysis and Outlook to 2028

    • 13.1 Global Oral Vaccines Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Oral Vaccines Consumption Forecast (2022-2028)

      • 13.2.2 Canada Oral Vaccines Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Oral Vaccines Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Oral Vaccines Consumption Forecast (2022-2028)

      • 13.3.2 UK Oral Vaccines Consumption Forecast (2022-2028)

      • 13.3.3 Spain Oral Vaccines Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Oral Vaccines Consumption Forecast (2022-2028)

      • 13.3.5 France Oral Vaccines Consumption Forecast (2022-2028)

      • 13.3.6 Italy Oral Vaccines Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Oral Vaccines Consumption Forecast (2022-2028)

      • 13.3.8 Finland Oral Vaccines Consumption Forecast (2022-2028)

      • 13.3.9 Norway Oral Vaccines Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Oral Vaccines Consumption Forecast (2022-2028)

      • 13.3.11 Poland Oral Vaccines Consumption Forecast (2022-2028)

      • 13.3.12 Russia Oral Vaccines Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Oral Vaccines Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Oral Vaccines Consumption Forecast (2022-2028)

      • 13.4.2 Japan Oral Vaccines Consumption Forecast (2022-2028)

      • 13.4.3 India Oral Vaccines Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Oral Vaccines Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Oral Vaccines Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Oral Vaccines Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Oral Vaccines Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Oral Vaccines Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Oral Vaccines Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Oral Vaccines Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Oral Vaccines Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Oral Vaccines Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Oral Vaccines Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Oral Vaccines Consumption Forecast (2022-2028)

      • 13.5.3 Chile Oral Vaccines Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Oral Vaccines Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Oral Vaccines Consumption Forecast (2022-2028)

      • 13.5.6 Peru Oral Vaccines Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Oral Vaccines Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Oral Vaccines Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Oral Vaccines Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Oral Vaccines Consumption Forecast (2022-2028)

      • 13.6.3 Oman Oral Vaccines Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Oral Vaccines Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Oral Vaccines Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Oral Vaccines Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Oral Vaccines Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Oral Vaccines Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Oral Vaccines Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Oral Vaccines Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Oral Vaccines Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Oral Vaccines Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Oral Vaccines

    • Figure of Oral Vaccines Picture

    • Table Global Oral Vaccines Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Oral Vaccines Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Rotavirus Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Global Cholera Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Global Oral Polio Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Public Consumption and Growth Rate (2017-2022)

    • Figure Global Private Consumption and Growth Rate (2017-2022)

    • Figure Global Oral Vaccines Consumption by Country (2017-2022)

    • Table North America Oral Vaccines Consumption by Country (2017-2022)

    • Figure United States Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Canada Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Mexico Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Table Europe Oral Vaccines Consumption by Country (2017-2022)

    • Figure Germany Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure UK Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Spain Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Belgium Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure France Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Italy Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Denmark Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Finland Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Norway Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Sweden Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Poland Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Russia Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Turkey Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Table APAC Oral Vaccines Consumption by Country (2017-2022)

    • Figure China Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Japan Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure India Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure South Korea Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Thailand Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Singapore Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Philippines Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Table South America Oral Vaccines Consumption by Country (2017-2022)

    • Figure Brazil Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Colombia Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Chile Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Argentina Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Peru Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Table GCC Oral Vaccines Consumption by Country (2017-2022)

    • Figure Bahrain Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Oman Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Qatar Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Table Africa Oral Vaccines Consumption by Country (2017-2022)

    • Figure Nigeria Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure South Africa Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Egypt Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Algeria Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Table Oceania Oral Vaccines Consumption by Country (2017-2022)

    • Figure Australia Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Table Halfkin Bio-Pharmaceuticals Company Details

    • Table Halfkin Bio-Pharmaceuticals Oral Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Halfkin Bio-Pharmaceuticals Oral Vaccines Main Business and Markets Served

    • Table Halfkin Bio-Pharmaceuticals Oral Vaccines Product Portfolio

    • Table GSK Company Details

    • Table GSK Oral Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table GSK Oral Vaccines Main Business and Markets Served

    • Table GSK Oral Vaccines Product Portfolio

    • Table Serum Institute Company Details

    • Table Serum Institute Oral Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Serum Institute Oral Vaccines Main Business and Markets Served

    • Table Serum Institute Oral Vaccines Product Portfolio

    • Table Valneva Company Details

    • Table Valneva Oral Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Valneva Oral Vaccines Main Business and Markets Served

    • Table Valneva Oral Vaccines Product Portfolio

    • Table Merck Company Details

    • Table Merck Oral Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Oral Vaccines Main Business and Markets Served

    • Table Merck Oral Vaccines Product Portfolio

    • Table Shanghai United Cell Company Details

    • Table Shanghai United Cell Oral Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Shanghai United Cell Oral Vaccines Main Business and Markets Served

    • Table Shanghai United Cell Oral Vaccines Product Portfolio

    • Table Sanofi Company Details

    • Table Sanofi Oral Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Oral Vaccines Main Business and Markets Served

    • Table Sanofi Oral Vaccines Product Portfolio

    • Table Bibcol Company Details

    • Table Bibcol Oral Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bibcol Oral Vaccines Main Business and Markets Served

    • Table Bibcol Oral Vaccines Product Portfolio

    • Table Bio-Med Company Details

    • Table Bio-Med Oral Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bio-Med Oral Vaccines Main Business and Markets Served

    • Table Bio-Med Oral Vaccines Product Portfolio

    • Table Tiantan Biological Company Details

    • Table Tiantan Biological Oral Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Tiantan Biological Oral Vaccines Main Business and Markets Served

    • Table Tiantan Biological Oral Vaccines Product Portfolio

    • Table PaxVax Company Details

    • Table PaxVax Oral Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table PaxVax Oral Vaccines Main Business and Markets Served

    • Table PaxVax Oral Vaccines Product Portfolio

    • Table EuBiologics Company Details

    • Table EuBiologics Oral Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table EuBiologics Oral Vaccines Main Business and Markets Served

    • Table EuBiologics Oral Vaccines Product Portfolio

    • Table Panacea Biotec Ltd Company Details

    • Table Panacea Biotec Ltd Oral Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Panacea Biotec Ltd Oral Vaccines Main Business and Markets Served

    • Table Panacea Biotec Ltd Oral Vaccines Product Portfolio

    • Table Vabiotech Company Details

    • Table Vabiotech Oral Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Vabiotech Oral Vaccines Main Business and Markets Served

    • Table Vabiotech Oral Vaccines Product Portfolio

    • Table Lanzhou Institute Company Details

    • Table Lanzhou Institute Oral Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Lanzhou Institute Oral Vaccines Main Business and Markets Served

    • Table Lanzhou Institute Oral Vaccines Product Portfolio

    • Figure Global Rotavirus Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cholera Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Oral Polio Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Public Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Private Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Oral Vaccines Consumption Forecast by Country (2022-2028)

    • Table North America Oral Vaccines Consumption Forecast by Country (2022-2028)

    • Figure United States Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Oral Vaccines Consumption Forecast by Country (2022-2028)

    • Figure Germany Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Oral Vaccines Consumption Forecast by Country (2022-2028)

    • Figure China Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Oral Vaccines Consumption Forecast by Country (2022-2028)

    • Figure Brazil Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Oral Vaccines Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Oral Vaccines Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Oral Vaccines Consumption Forecast by Country (2022-2028)

    • Figure Australia Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US